Molecular Biology of Lung Cancer: Clinical Implications

Jill E. Larsen, John D. Minna

Research output: Contribution to journalReview articlepeer-review

166 Scopus citations


Lung cancer is a heterogeneous disease clinically, biologically, histologically, and molecularly. Understanding the molecular causes of this heterogeneity, which might reflect changes occurring in different classes of epithelial cells or different molecular changes occurring in the same target lung epithelial cells, is the focus of current research. Identifying the genes and pathways involved, determining how they relate to the biological behavior of lung cancer, and their utility as diagnostic and therapeutic targets are important basic and translational research issues. This article reviews current information on the key molecular steps in lung cancer pathogenesis, their timing, and clinical implications.

Original languageEnglish (US)
Pages (from-to)703-740
Number of pages38
JournalClinics in Chest Medicine
Issue number4
StatePublished - Dec 2011


  • Gene mutation
  • Genome-wide analysis
  • Lung cancer
  • Lung carcinogenesis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Molecular Biology of Lung Cancer: Clinical Implications'. Together they form a unique fingerprint.

Cite this